February 28, 2024 · Form 4 insider transaction
BENEVICH ERIC bought 53,143 shares of Neurocrine Biosciences, Inc. at $43.24 per share, a transaction worth $2.30M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.